However, differences in the expression of other markers were observed, including lower expression of CD38, CD62L, and CD49d and higher expression of LAIR-1, CXCR5, and CCR6 on CLL-type MBL compared to CLL. This evidence concerns the gene ITGA4 and B-cell chronic lymphocytic leukemia.